Neuropeptide Y (3-36) (human, rat)
目录号 : GC61875An endogenous C-terminal NPY fragment
Cas No.:150138-78-6
Sample solution is provided at 25 µL, 10mM.
Neuropeptide Y (NPY) (3-36) is a C-terminal fragment of NPY, a neuropeptide involved in controlling appetite, blood pressure, cardiac contractility, and intestinal secretion.1 NPY (3-36) is an endogenous peptide produced by cleavage of NPY by dipeptidyl peptidase 4 (DPP-4).2,3 It binds selectively to the NPY receptor Y2 (Ki = 0.41 nM in CHP 234 cells) over the Y1 receptor, where it does not bind at concentrations up to 1 ?M. NPY (3-36) (0.1 nM) increases migration of human umbilical vein endothelial cells (HUVECs) by 80% after 12 hours in an in vitro wound closure assay.4 NPY (3-36) corresponds to residues 3-36 of the human and rat protein sequence.
1.Balasubramaniam, A.Neuropeptide Y family of hormones: Receptor subtypes and antagonistsPeptides18(3)445-457(1997) 2.Grandt, D., Schimiczek, M., Rascher, W., et al.Neuropeptide Y 3-36 is an endogenous ligand selective for Y2 receptorsRegul. Pept.67(1)33-37(1996) 3.Medeiros, M.d.S., and Turner, A.J.Metabolism and functions of neuropeptide YNeurochem. Res.21(9)1125-1132(1996) 4.Ghersi, G., Chen, W.-T., Lee, E.W., et al.Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to woundingPeptides22(3)453-458(2001)
Cas No. | 150138-78-6 | SDF | |
分子式 | C175H269N53O54S | 分子量 | 4011.5 |
溶解度 | DMSO : 100 mg/mL (24.93 mM; Need ultrasonic) | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 0.2493 mL | 1.2464 mL | 2.4928 mL |
5 mM | 0.0499 mL | 0.2493 mL | 0.4986 mL |
10 mM | 0.0249 mL | 0.1246 mL | 0.2493 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >95.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet